MAGNESIUM OXIDE

MAGNESIUM OXIDE was reported 42445 times

MAGNESIUM OXIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 58 0.4462
1 SLEEP DISORDER THERAPY 83 0.4192
2 PULMONARY VASCULITIS 219 0.4071
3 VAGINAL FLATULENCE 119 0.3927
4 TOTAL LUNG CAPACITY ABNORMAL 128 0.3290
5 APPENDICOLITH 104 0.2687
6 ANALGESIC THERAPY 85 0.2648
7 SPIROMETRY ABNORMAL 158 0.2642
8 DRUG THERAPY 84 0.2478
9 MITE ALLERGY 161 0.2458
10 CONGENITAL HIATUS HERNIA 55 0.2412
11 MALIGNANT MELANOMA STAGE 0 46 0.2201
12 ANTICOAGULANT THERAPY 59 0.2077
13 CAPILLARITIS 57 0.2065
14 MYCOTIC ALLERGY 163 0.1906
15 DUST ALLERGY 162 0.1651
16 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 113 0.1542
17 NEURITIS 229 0.1482
18 HYPERMAGNESAEMIA 87 0.1332
19 GRANULOMA SKIN 99 0.1206
20 CONJUNCTIVITIS ALLERGIC 170 0.1147
21 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 190 0.0931
22 RESPIRATORY SYMPTOM 260 0.0913
23 FEMALE GENITAL TRACT FISTULA 143 0.0837
24 BLOOD PARATHYROID HORMONE DECREASED 104 0.0701
25 NORMOCHROMIC NORMOCYTIC ANAEMIA 183 0.0609
26 HYPERPHOSPHATAEMIA 126 0.0586
27 RADICULOPATHY 147 0.0557
28 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 51 0.0550
29 PULMONARY ALVEOLAR HAEMORRHAGE 267 0.0476
30 FORCED EXPIRATORY VOLUME DECREASED 131 0.0462
31 PANNICULITIS 111 0.0458
32 CHRONIC SINUSITIS 171 0.0455
33 PROCTITIS 126 0.0449
34 BLOOD PHOSPHORUS INCREASED 119 0.0435
35 NEPHROGENIC ANAEMIA 201 0.0433
36 UPPER RESPIRATORY TRACT INFLAMMATION 52 0.0433
37 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 44 0.0414
38 NEUROLOGICAL SYMPTOM 227 0.0397
39 RHEUMATOID NODULE 105 0.0381
40 HYPERPARATHYROIDISM SECONDARY 95 0.0379
41 BREATH SOUNDS ABNORMAL 172 0.0348
42 FULMINANT TYPE 1 DIABETES MELLITUS 34 0.0330
43 IMMUNE-MEDIATED HEPATIC DISORDER 58 0.0297
44 DRUG TOLERANCE DECREASED 82 0.0292
45 ARTERIOSCLEROSIS CORONARY ARTERY 191 0.0288
46 BLOOD MAGNESIUM DECREASED 244 0.0282
47 TOTAL LUNG CAPACITY DECREASED 44 0.0275
48 FULL BLOOD COUNT ABNORMAL 285 0.0269
49 LUNG OPACITY 70 0.0265
50 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 128 0.0253
51 MARASMUS 38 0.0250
52 HYPOPHOSPHATAEMIA 182 0.0246
53 NEOPLASM SKIN 38 0.0245
54 RHEUMATOID FACTOR POSITIVE 137 0.0237
55 OBSTRUCTIVE AIRWAYS DISORDER 259 0.0233
56 ARTERIOSCLEROSIS 217 0.0230
57 ESSENTIAL HYPERTENSION 42 0.0229
58 PULMONARY FIBROSIS 433 0.0225
59 STOMA SITE PAIN 32 0.0218
60 BLOOD URIC ACID INCREASED 125 0.0216
61 SKIN NECROSIS 111 0.0214
62 CANCER PAIN 54 0.0211
63 PLEURITIC PAIN 57 0.0206
64 VASCULITIS 239 0.0205
65 IRON DEFICIENCY 91 0.0202
66 AORTIC STENOSIS 70 0.0201
67 END STAGE RENAL DISEASE 365 0.0200
68 RECALLED PRODUCT 34 0.0196
69 DISTRIBUTIVE SHOCK 44 0.0194
70 MACULAR DEGENERATION 231 0.0193
71 RADIATION PNEUMONITIS 41 0.0191
72 MYASTHENIA GRAVIS 154 0.0190
73 PHYSICAL DECONDITIONING 49 0.0190
74 HYPOMAGNESAEMIA 261 0.0187
75 DISSEMINATED INTRAVASCULAR COAGULATION 257 0.0182
76 INFUSION SITE DISCHARGE 32 0.0182
77 HYPERCALCAEMIA 225 0.0182
78 ENTEROCOLITIS 105 0.0182
79 PRE-EXISTING CONDITION IMPROVED 112 0.0179
80 HYPERURICAEMIA 72 0.0175
81 CHOLANGITIS 107 0.0172
82 REBOUND ACID HYPERSECRETION 52 0.0172
83 DRUG ERUPTION 300 0.0169
84 ILEUS 208 0.0167
85 BENIGN PROSTATIC HYPERPLASIA 86 0.0166
86 HEPATIC FUNCTION ABNORMAL 614 0.0164
87 IRON DEFICIENCY ANAEMIA 148 0.0160
88 APPENDICITIS 149 0.0159
89 PNEUMONIA ASPIRATION 396 0.0158
90 ORAL CANDIDIASIS 207 0.0157
91 NON-SMALL CELL LUNG CANCER 75 0.0156
92 PNEUMONIA BACTERIAL 143 0.0156
93 BLOOD CHLORIDE DECREASED 40 0.0155
94 ILEUS PARALYTIC 69 0.0154
95 INTERSTITIAL LUNG DISEASE 742 0.0153
96 HYPOXIA 537 0.0152
97 VENTRICULAR FIBRILLATION 169 0.0152
98 ULCER 237 0.0149
99 TROPONIN INCREASED 112 0.0147
100 HYPOALBUMINAEMIA 114 0.0146
101 NODULE 191 0.0146
102 BLOOD ALBUMIN DECREASED 115 0.0145
103 RED BLOOD CELL SEDIMENTATION RATE INCREASED 159 0.0144
104 PNEUMOCYSTIS JIROVECI PNEUMONIA 32 0.0143
105 HAEMOPTYSIS 397 0.0142
106 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 240 0.0141
107 COMPRESSION FRACTURE 75 0.0140
108 IMMUNE-MEDIATED ENTEROCOLITIS 51 0.0139
109 RESPIRATORY TRACT INFECTION VIRAL 32 0.0137
110 BRAIN NATRIURETIC PEPTIDE INCREASED 42 0.0136
111 HAEMORRHAGE SUBCUTANEOUS 48 0.0135
112 HYPOTHYROIDISM 424 0.0133
113 DECUBITUS ULCER 108 0.0132
114 SPINAL COMPRESSION FRACTURE 109 0.0132
115 CARDIAC FAILURE ACUTE 87 0.0130
116 HYPERLIPIDAEMIA 156 0.0130
117 CYTOMEGALOVIRUS VIRAEMIA 58 0.0130
118 VAGINAL DISCHARGE 131 0.0129
119 DEVICE INFUSION ISSUE 32 0.0129
120 BLOOD LACTATE DEHYDROGENASE INCREASED 201 0.0127
121 NEUTROPHIL COUNT DECREASED 508 0.0125
122 HEPATIC ENCEPHALOPATHY 116 0.0124
123 BLOOD CALCIUM INCREASED 109 0.0124
124 HYPERVOLAEMIA 61 0.0123
125 FEMORAL NECK FRACTURE 63 0.0123
126 CARDIAC FAILURE CHRONIC 52 0.0122
127 ALTERED STATE OF CONSCIOUSNESS 264 0.0122
128 FEBRILE NEUTROPENIA 807 0.0122
129 PRODUCT ADMINISTRATION INTERRUPTED 95 0.0121
130 CARBOHYDRATE ANTIGEN 125 INCREASED 41 0.0120
131 METABOLIC ENCEPHALOPATHY 36 0.0120
132 PARAESTHESIA ORAL 173 0.0120
133 STAPHYLOCOCCAL BACTERAEMIA 52 0.0120
134 PROTEIN TOTAL DECREASED 44 0.0117
135 ASCITES 342 0.0116
136 ASPIRATION 126 0.0115
137 CEREBRAL INFARCTION 279 0.0114
138 LYMPHOCYTE COUNT DECREASED 200 0.0113
139 RHINITIS ALLERGIC 50 0.0112
140 TUMOUR HAEMORRHAGE 32 0.0112
141 ASPARTATE AMINOTRANSFERASE INCREASED 593 0.0112
142 RIGHT VENTRICULAR FAILURE 77 0.0110
143 LUMBAR SPINAL STENOSIS 32 0.0109
144 LOWER GASTROINTESTINAL HAEMORRHAGE 80 0.0108
145 CHEST X-RAY ABNORMAL 33 0.0108
146 ATELECTASIS 104 0.0108
147 HAEMORRHAGIC ANAEMIA 47 0.0107
148 BLOOD POTASSIUM INCREASED 172 0.0106
149 C-REACTIVE PROTEIN INCREASED 385 0.0106
150 AMYLASE INCREASED 39 0.0106
151 BLOOD UREA INCREASED 176 0.0105
152 PNEUMOCYSTIS JIROVECII PNEUMONIA 105 0.0104
153 HEPATITIS FULMINANT 31 0.0104
154 FAILURE TO THRIVE 54 0.0104
155 CARDIOGENIC SHOCK 149 0.0104
156 AMMONIA INCREASED 52 0.0102
157 CYTOKINE RELEASE SYNDROME 204 0.0102
158 PYELONEPHRITIS 88 0.0101
159 BACTERIAL INFECTION 189 0.0101
160 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 104 0.0101
161 GASTROINTESTINAL PERFORATION 42 0.0101
162 DELIRIUM 350 0.0101
163 PLATELET COUNT DECREASED 1069 0.0100
164 CHRONIC KIDNEY DISEASE 760 0.0100
165 PRESCRIBED UNDERDOSE 199 0.0100
166 HYPERCHOLESTEROLAEMIA 96 0.0099
167 ACUTE RESPIRATORY FAILURE 191 0.0099
168 GOUT 177 0.0099
169 PARONYCHIA 43 0.0098
170 ATRIAL FLUTTER 78 0.0098
171 PULMONARY TOXICITY 69 0.0097
172 INFUSION SITE HAEMORRHAGE 32 0.0097
173 ELECTROLYTE IMBALANCE 113 0.0097
174 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 32 0.0097
175 CYSTITIS HAEMORRHAGIC 39 0.0097
176 HAEMOGLOBIN INCREASED 44 0.0096
177 HYPERAMMONAEMIA 48 0.0096
178 APLASIA PURE RED CELL 33 0.0096
179 BLOOD POTASSIUM DECREASED 287 0.0095
180 HYPONATRAEMIA 537 0.0095
181 INFUSION SITE PAIN 122 0.0095
182 PULMONARY HYPERTENSION 197 0.0094
183 HICCUPS 77 0.0094
184 HAEMATOCRIT DECREASED 186 0.0094
185 BASAL CELL CARCINOMA 146 0.0093
186 TRANSFUSION 98 0.0093
187 HYDRONEPHROSIS 70 0.0093
188 PLEURAL EFFUSION 567 0.0093
189 VASCULAR DEVICE INFECTION 42 0.0092
190 HYPERKALAEMIA 324 0.0092
191 HYPERNATRAEMIA 46 0.0092
192 HYPOVOLAEMIA 54 0.0092
193 MALNUTRITION 103 0.0092
194 TUMOUR LYSIS SYNDROME 81 0.0092
195 CHOLECYSTITIS ACUTE 52 0.0092
196 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 35 0.0092
197 BLOOD SODIUM DECREASED 172 0.0091
198 HYPOKALAEMIA 419 0.0091
199 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 435 0.0090
200 URINE OUTPUT DECREASED 79 0.0090
201 GASTRIC ULCER HAEMORRHAGE 50 0.0090
202 RED BLOOD CELL COUNT DECREASED 257 0.0090
203 SKIN ULCER 231 0.0089
204 ADRENAL INSUFFICIENCY 108 0.0089
205 LIVER DISORDER 394 0.0089
206 LUNG DISORDER 435 0.0089
207 BACTERAEMIA 105 0.0088
208 BLOOD ALKALINE PHOSPHATASE INCREASED 219 0.0088
209 OESOPHAGEAL CANDIDIASIS 35 0.0088
210 ALANINE AMINOTRANSFERASE INCREASED 539 0.0088
211 HYPOCALCAEMIA 165 0.0087
212 DERMATITIS ACNEIFORM 53 0.0087
213 HAEMORRHAGIC DIATHESIS 31 0.0087
214 CLOSTRIDIUM DIFFICILE COLITIS 92 0.0087
215 RED CELL DISTRIBUTION WIDTH INCREASED 36 0.0087
216 LARGE INTESTINE PERFORATION 60 0.0086
217 PNEUMONIA FUNGAL 34 0.0086
218 BLOOD CREATININE INCREASED 561 0.0086
219 SLEEP APNOEA SYNDROME 163 0.0085
220 LUMBAR VERTEBRAL FRACTURE 39 0.0085
221 MULTIPLE ORGAN DYSFUNCTION SYNDROME 241 0.0085
222 STAPHYLOCOCCAL SEPSIS 42 0.0085
223 SMALL INTESTINAL OBSTRUCTION 104 0.0084
224 COLITIS 318 0.0084
225 NEURALGIA 203 0.0083
226 BLOOD CALCIUM DECREASED 93 0.0083
227 FLUID OVERLOAD 120 0.0082
228 ANAEMIA 1568 0.0082
229 AORTIC DISSECTION 34 0.0082
230 SYNOVITIS 148 0.0082
231 UPPER GASTROINTESTINAL HAEMORRHAGE 138 0.0082
232 SEPSIS 905 0.0081
233 PEMPHIGOID 61 0.0081
234 CARDIOMEGALY 99 0.0080
235 BLOOD TEST ABNORMAL 113 0.0080
236 PROTHROMBIN TIME PROLONGED 48 0.0080
237 PNEUMOTHORAX 125 0.0079
238 RENAL IMPAIRMENT 661 0.0079
239 PROTEIN URINE PRESENT 39 0.0078
240 RENAL FAILURE CHRONIC 60 0.0078
241 SQUAMOUS CELL CARCINOMA OF SKIN 47 0.0078
242 PRODUCTIVE COUGH 370 0.0077
243 RALES 45 0.0077
244 VENTRICULAR EXTRASYSTOLES 80 0.0077
245 PERIPHERAL SENSORY NEUROPATHY 45 0.0077
246 SEASONAL ALLERGY 108 0.0076
247 ACUTE KIDNEY INJURY 1162 0.0076
248 INFUSION SITE ERYTHEMA 64 0.0076
249 CHOLECYSTITIS 90 0.0075
250 MICTURITION URGENCY 86 0.0075
251 CYTOMEGALOVIRUS INFECTION 125 0.0075
252 DRUG TOLERANCE 38 0.0075
253 ENTEROCOCCAL INFECTION 36 0.0074
254 MITRAL VALVE INCOMPETENCE 84 0.0074
255 SUPRAVENTRICULAR TACHYCARDIA 71 0.0074
256 SPINAL OSTEOARTHRITIS 65 0.0074
257 KIDNEY TRANSPLANT REJECTION 35 0.0073
258 ERYTHEMA MULTIFORME 68 0.0073
259 DYSLIPIDAEMIA 37 0.0073
260 INFUSION RELATED REACTION 481 0.0072
261 RENAL TUBULAR NECROSIS 71 0.0072
262 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 513 0.0072
263 GENERALISED OEDEMA 89 0.0072
264 DIVERTICULUM 51 0.0072
265 DYSPNOEA EXERTIONAL 270 0.0072
266 BLOOD BILIRUBIN INCREASED 193 0.0071
267 DEPRESSED LEVEL OF CONSCIOUSNESS 282 0.0071
268 PULMONARY MASS 105 0.0070
269 CELLULITIS 355 0.0070
270 WHITE BLOOD CELL COUNT DECREASED 762 0.0070
271 ABDOMINAL ABSCESS 31 0.0070
272 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 365 0.0070
273 ANOREXIA 90 0.0070
274 RENAL CELL CARCINOMA 34 0.0069
275 ATRIAL FIBRILLATION 676 0.0069
276 GASTROENTERITIS 101 0.0069
277 MENTAL STATUS CHANGES 192 0.0069
278 CONSTIPATION 1504 0.0069
279 FREQUENT BOWEL MOVEMENTS 186 0.0069
280 HOSPICE CARE 68 0.0069
281 VITAMIN D DEFICIENCY 67 0.0069
282 COVID-19 PNEUMONIA 81 0.0069
283 C-REACTIVE PROTEIN ABNORMAL 44 0.0069
284 PERFORMANCE STATUS DECREASED 32 0.0069
285 DEHYDRATION 914 0.0068
286 TUBULOINTERSTITIAL NEPHRITIS 128 0.0068
287 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 117 0.0068
288 GRAFT VERSUS HOST DISEASE 49 0.0068
289 TASTE DISORDER 138 0.0068
290 SKIN ABRASION 32 0.0068
291 RESPIRATORY FAILURE 492 0.0067
292 GAMMA-GLUTAMYLTRANSFERASE INCREASED 149 0.0067
293 EOSINOPHIL COUNT INCREASED 56 0.0067
294 SUBDURAL HAEMATOMA 96 0.0067
295 PULMONARY ARTERIAL HYPERTENSION 97 0.0067
296 OEDEMA 362 0.0067
297 INFUSION SITE SWELLING 42 0.0067
298 RECTAL HAEMORRHAGE 286 0.0067
299 ABDOMINAL TENDERNESS 33 0.0066
300 NEUTROPHIL COUNT INCREASED 68 0.0066
301 PNEUMONIA 2146 0.0066
302 DECREASED APPETITE 1539 0.0066
303 PERICARDIAL EFFUSION 153 0.0066
304 LUNG INFILTRATION 58 0.0066
305 WHITE BLOOD CELL COUNT INCREASED 250 0.0065
306 PNEUMONITIS 177 0.0065
307 HIATUS HERNIA 84 0.0065
308 SEPTIC SHOCK 282 0.0065
309 PANCYTOPENIA 362 0.0065
310 HAEMOGLOBIN DECREASED 665 0.0065
311 WHEEZING 383 0.0065
312 PULMONARY EMBOLISM 612 0.0064
313 ENCEPHALOPATHY 158 0.0064
314 HUMERUS FRACTURE 31 0.0064
315 BLOOD PRESSURE DECREASED 427 0.0064
316 SUDDEN DEATH 68 0.0064
317 PROCEDURAL PAIN 178 0.0064
318 HYPOPHAGIA 164 0.0064
319 PLEURISY 38 0.0064
320 SOMNAMBULISM 42 0.0064
321 CARDIAC FAILURE CONGESTIVE 513 0.0064
322 PSYCHIATRIC SYMPTOM 47 0.0064
323 GASTRIC ULCER 121 0.0064
324 HAEMORRHOIDAL HAEMORRHAGE 31 0.0063
325 URINARY RETENTION 211 0.0063
326 ON AND OFF PHENOMENON 35 0.0063
327 STOMATITIS 382 0.0063
328 MALIGNANT NEOPLASM PROGRESSION 645 0.0063
329 FLANK PAIN 59 0.0063
330 MYELODYSPLASTIC SYNDROME 91 0.0063
331 RENAL FAILURE 832 0.0063
332 THROMBOSIS 504 0.0063
333 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 37 0.0062
334 BRONCHIECTASIS 42 0.0062
335 DERMATITIS CONTACT 71 0.0062
336 DRUG-INDUCED LIVER INJURY 195 0.0062
337 VENTRICULAR TACHYCARDIA 102 0.0062
338 INTESTINAL ISCHAEMIA 34 0.0062
339 RENAL CYST 49 0.0062
340 TRICUSPID VALVE INCOMPETENCE 49 0.0062
341 CARDIAC FAILURE 495 0.0062
342 ORTHOSTATIC HYPOTENSION 107 0.0061
343 SHOCK HAEMORRHAGIC 50 0.0061
344 LIPASE INCREASED 47 0.0061
345 MALABSORPTION 32 0.0061
346 UPPER RESPIRATORY TRACT INFECTION 282 0.0061
347 COLITIS ISCHAEMIC 41 0.0061
348 SERUM FERRITIN INCREASED 32 0.0061
349 OSTEOMYELITIS 109 0.0060
350 STRESS CARDIOMYOPATHY 35 0.0060
351 IMPAIRED GASTRIC EMPTYING 82 0.0060
352 MOUTH HAEMORRHAGE 44 0.0060
353 TRANSPLANT REJECTION 48 0.0060
354 PERITONITIS 124 0.0060
355 DIZZINESS POSTURAL 58 0.0060
356 COLON CANCER 89 0.0060
357 ACUTE MYELOID LEUKAEMIA 93 0.0060
358 RENAL FAILURE ACUTE 252 0.0059
359 ENTERITIS 38 0.0059
360 LARGE INTESTINE POLYP 41 0.0059
361 PROTEINURIA 112 0.0059
362 LEUKOCYTOSIS 106 0.0059
363 FULL BLOOD COUNT DECREASED 117 0.0058
364 HYPOGAMMAGLOBULINAEMIA 38 0.0058
365 DEVICE RELATED INFECTION 89 0.0058
366 GASTROINTESTINAL HAEMORRHAGE 482 0.0058
367 URINARY TRACT INFECTION 982 0.0058
368 ANAL ABSCESS 31 0.0057
369 BLOOD CREATINE PHOSPHOKINASE INCREASED 165 0.0057
370 OEDEMA PERIPHERAL 694 0.0057
371 PLASMA CELL MYELOMA 222 0.0057
372 MYOSITIS 51 0.0057
373 NEPHROPATHY 53 0.0057
374 LEFT VENTRICULAR DYSFUNCTION 38 0.0057
375 DIABETES MELLITUS 431 0.0056
376 INTESTINAL OBSTRUCTION 213 0.0056
377 ENCEPHALITIS 39 0.0056
378 UROSEPSIS 52 0.0056
379 HYPERGLYCAEMIA 205 0.0056
380 SUBARACHNOID HAEMORRHAGE 57 0.0056
381 PYREXIA 1925 0.0056
382 PARKINSONISM 54 0.0055
383 SHOCK 127 0.0055
384 DECREASED ACTIVITY 59 0.0055
385 METASTASES TO LIVER 96 0.0055
386 GLOMERULAR FILTRATION RATE DECREASED 67 0.0054
387 DIFFUSE LARGE B-CELL LYMPHOMA 42 0.0054
388 HEPATIC CIRRHOSIS 102 0.0054
389 MELAENA 119 0.0054
390 HAEMATURIA 185 0.0054
391 NEUROPATHY PERIPHERAL 513 0.0054
392 DUODENAL ULCER 38 0.0054
393 ELECTROCARDIOGRAM ABNORMAL 42 0.0053
394 LYMPHOEDEMA 37 0.0053
395 HAEMATOCHEZIA 295 0.0053
396 LIVER FUNCTION TEST INCREASED 114 0.0053
397 INTERVERTEBRAL DISC DEGENERATION 49 0.0053
398 SINUS TACHYCARDIA 75 0.0053
399 FEEDING DISORDER 107 0.0053
400 NEPHROTIC SYNDROME 36 0.0052
401 PULMONARY OEDEMA 235 0.0052
402 BRAIN FOG 82 0.0052
403 OLIGURIA 32 0.0051
404 SKIN LACERATION 56 0.0051
405 BLOOD PRESSURE DIASTOLIC DECREASED 38 0.0051
406 POLYURIA 42 0.0051
407 ANAL INCONTINENCE 46 0.0051
408 INCREASED TENDENCY TO BRUISE 47 0.0051
409 NOCTURIA 62 0.0051
410 ESCHERICHIA INFECTION 42 0.0051
411 ACIDOSIS 39 0.0051
412 JOINT INJURY 109 0.0051
413 MENINGITIS 34 0.0051
414 ATRIOVENTRICULAR BLOCK COMPLETE 34 0.0051
415 GASTRITIS 133 0.0050
416 ABDOMINAL PAIN 1174 0.0050
417 FLUID RETENTION 255 0.0050
418 ABDOMINAL DISTENSION 523 0.0050
419 PULMONARY CONGESTION 66 0.0050
420 DYSURIA 184 0.0050
421 AORTIC ANEURYSM 38 0.0050
422 INTESTINAL PERFORATION 56 0.0050
423 CONTRAINDICATED PRODUCT ADMINISTERED 151 0.0050
424 HAEMORRHOIDS 97 0.0050
425 HYPOGLYCAEMIA 240 0.0049
426 METASTASES TO BONE 81 0.0049
427 METASTASES TO LUNG 57 0.0049
428 GASTROOESOPHAGEAL REFLUX DISEASE 397 0.0049
429 METASTASES TO LYMPH NODES 33 0.0049
430 OESOPHAGITIS 53 0.0048
431 SPUTUM DISCOLOURED 46 0.0048
432 ASTHMA 548 0.0048
433 WOUND INFECTION 53 0.0048
434 DRUG LEVEL INCREASED 80 0.0048
435 CEREBRAL HAEMORRHAGE 173 0.0048
436 HAEMOGLOBIN ABNORMAL 31 0.0048
437 CYTOPENIA 59 0.0048
438 THROMBOCYTOPENIA 538 0.0048
439 HEPATIC FAILURE 145 0.0048
440 EPISTAXIS 358 0.0048
441 LIVE BIRTH 40 0.0048
442 CYSTITIS 152 0.0048
443 BRONCHOPULMONARY ASPERGILLOSIS 37 0.0048
444 EMPHYSEMA 48 0.0048
445 CARDIAC MURMUR 41 0.0047
446 HYPERBILIRUBINAEMIA 49 0.0047
447 SKIN INFECTION 53 0.0047
448 HEPATIC ENZYME INCREASED 322 0.0047
449 RHABDOMYOLYSIS 196 0.0047
450 DELUSION 73 0.0047
451 OXYGEN SATURATION DECREASED 264 0.0047
452 HYPERTENSION 995 0.0047
453 CORONARY ARTERY DISEASE 142 0.0047
454 WEIGHT FLUCTUATION 49 0.0047
455 RENAL DISORDER 218 0.0047
456 BONE MARROW FAILURE 95 0.0047
457 CLOSTRIDIUM DIFFICILE INFECTION 102 0.0047
458 CARDIOMYOPATHY 69 0.0047
459 DEMENTIA 130 0.0046
460 PURPURA 41 0.0046
461 HYPERTHYROIDISM 67 0.0046
462 RIB FRACTURE 95 0.0046
463 GASTROENTERITIS VIRAL 83 0.0046
464 THIRST 82 0.0046
465 INTERNATIONAL NORMALISED RATIO INCREASED 130 0.0046
466 HAEMODIALYSIS 38 0.0045
467 ECCHYMOSIS 31 0.0045
468 RENAL INJURY 134 0.0045
469 HEPATOCELLULAR CARCINOMA 34 0.0045
470 ACUTE RESPIRATORY DISTRESS SYNDROME 79 0.0045
471 LIGAMENT SPRAIN 44 0.0044
472 VITAMIN D DECREASED 38 0.0044
473 NERVE COMPRESSION 41 0.0044
474 COAGULOPATHY 74 0.0044
475 EJECTION FRACTION DECREASED 69 0.0044
476 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 103 0.0044
477 FAECES SOFT 32 0.0044
478 INTERNAL HAEMORRHAGE 50 0.0044
479 HYPOTENSION 877 0.0044
480 UPPER-AIRWAY COUGH SYNDROME 36 0.0044
481 ECONOMIC PROBLEM 66 0.0044
482 PAIN IN JAW 123 0.0043
483 DENTAL CARIES 48 0.0043
484 DEVICE OCCLUSION 61 0.0043
485 PSEUDOMONAS INFECTION 37 0.0043
486 DIARRHOEA 2784 0.0043
487 BRONCHITIS 319 0.0043
488 STAPHYLOCOCCAL INFECTION 142 0.0043
489 CARDIO-RESPIRATORY ARREST 180 0.0043
490 HAEMATEMESIS 109 0.0043
491 SALIVARY HYPERSECRETION 43 0.0043
492 HEAD INJURY 136 0.0043
493 HEPATIC STEATOSIS 80 0.0043
494 FALL 1424 0.0043
495 SPLENOMEGALY 50 0.0043
496 HEPATITIS 109 0.0043
497 RESPIRATORY SYNCYTIAL VIRUS INFECTION 37 0.0042
498 DRY MOUTH 344 0.0042
499 DYSPEPSIA 416 0.0042
500 FAECES DISCOLOURED 91 0.0042
501 DIVERTICULITIS 116 0.0042
502 ARTHROPATHY 232 0.0042
503 ELECTROCARDIOGRAM QT PROLONGED 150 0.0042
504 ORAL PAIN 93 0.0041
505 RASH PRURITIC 225 0.0041
506 SLEEP DISORDER 293 0.0041
507 HYPERSOMNIA 119 0.0041
508 OBESITY 66 0.0041
509 BLOOD CHOLESTEROL INCREASED 193 0.0041
510 KIDNEY INFECTION 81 0.0041
511 GASTROINTESTINAL INFECTION 37 0.0041
512 HERPES ZOSTER 237 0.0041
513 RESTLESS LEGS SYNDROME 75 0.0041
514 TRANSIENT ISCHAEMIC ATTACK 139 0.0041
515 ARTHRITIS 324 0.0041
516 DISEASE PROGRESSION 487 0.0041
517 CONDITION AGGRAVATED 1251 0.0041
518 BLOOD URINE PRESENT 78 0.0041
519 BLOOD PRESSURE SYSTOLIC INCREASED 80 0.0041
520 WEIGHT DECREASED 1141 0.0041
521 MULTIPLE ALLERGIES 32 0.0041
522 IMMUNOSUPPRESSION 36 0.0041
523 DEEP VEIN THROMBOSIS 265 0.0041
524 ANKLE FRACTURE 63 0.0041
525 DIABETES MELLITUS INADEQUATE CONTROL 72 0.0041
526 CONTUSION 391 0.0041
527 BLOOD IRON DECREASED 48 0.0040
528 OSTEONECROSIS OF JAW 100 0.0040
529 OSTEOARTHRITIS 171 0.0040
530 METASTASES TO CENTRAL NERVOUS SYSTEM 52 0.0040
531 PRESYNCOPE 98 0.0040
532 INFLAMMATION 208 0.0040
533 PERIPHERAL SWELLING 617 0.0040
534 TRANSAMINASES INCREASED 89 0.0040
535 RESPIRATORY TRACT INFECTION 104 0.0040
536 LUNG INFECTION 62 0.0040
537 PRODUCT DISTRIBUTION ISSUE 37 0.0040
538 PLATELET COUNT INCREASED 52 0.0040
539 DYSPNOEA 2257 0.0040
540 DRUG INTOLERANCE 385 0.0040
541 DYSPHONIA 233 0.0040
542 COLITIS ULCERATIVE 178 0.0040
543 ROTATOR CUFF SYNDROME 51 0.0040
544 ANURIA 34 0.0039
545 PETECHIAE 41 0.0039
546 MYOCARDITIS 45 0.0039
547 CHOLELITHIASIS 128 0.0039
548 TACHYPNOEA 53 0.0039
549 NEOPLASM PROGRESSION 135 0.0039
550 MUSCULOSKELETAL STIFFNESS 340 0.0039
551 NEUTROPENIA 523 0.0038
552 DYSPHAGIA 365 0.0038
553 BODY HEIGHT DECREASED 41 0.0038
554 BRADYCARDIA 203 0.0038
555 SCIATICA 61 0.0038
556 MULTI-ORGAN FAILURE 66 0.0038
557 MUSCLE STRAIN 33 0.0038
558 HOT FLUSH 287 0.0038
559 VOMITING 1789 0.0038
560 NAUSEA 3003 0.0038
561 LOSS OF CONSCIOUSNESS 486 0.0038
562 MUSCULAR WEAKNESS 431 0.0038
563 CANDIDA INFECTION 64 0.0038
564 POLLAKIURIA 158 0.0038
565 DEAFNESS 99 0.0038
566 SOMNOLENCE 762 0.0038
567 JOINT DISLOCATION 40 0.0038
568 BODY TEMPERATURE INCREASED 77 0.0038
569 MYOCLONUS 45 0.0038
570 BLOOD PRESSURE ABNORMAL 75 0.0038
571 ASTHENIA 1416 0.0038
572 HALLUCINATION, VISUAL 79 0.0037
573 EMBOLISM 31 0.0037
574 ACUTE MYOCARDIAL INFARCTION 110 0.0037
575 HEMIPLEGIA 31 0.0037
576 LOCALISED INFECTION 90 0.0037
577 LIMB INJURY 101 0.0037
578 MUSCLE TIGHTNESS 60 0.0037
579 HYSTERECTOMY 32 0.0037
580 INCONTINENCE 39 0.0037
581 BACK INJURY 40 0.0037
582 TOXIC SKIN ERUPTION 37 0.0037
583 SWELLING 343 0.0037
584 GINGIVAL BLEEDING 50 0.0037
585 SINUS DISORDER 72 0.0036
586 BLOOD PRESSURE INCREASED 555 0.0036
587 BLADDER DISORDER 36 0.0036
588 OSTEOPENIA 55 0.0036
589 LYMPHOMA 56 0.0036
590 POST PROCEDURAL HAEMORRHAGE 42 0.0036
591 MYOCARDIAL ISCHAEMIA 41 0.0036
592 STEVENS-JOHNSON SYNDROME 80 0.0036
593 CARPAL TUNNEL SYNDROME 50 0.0036
594 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 34 0.0036
595 LABORATORY TEST ABNORMAL 105 0.0036
596 HYPOTHERMIA 36 0.0036
597 PHARYNGITIS 44 0.0035
598 VIRAL INFECTION 118 0.0035
599 FRACTURE 67 0.0035
600 INSOMNIA 941 0.0035
601 RESTLESSNESS 129 0.0035
602 INTERVERTEBRAL DISC PROTRUSION 77 0.0035
603 EAR DISCOMFORT 36 0.0035
604 JAUNDICE 94 0.0035
605 PULMONARY THROMBOSIS 38 0.0035
606 OVARIAN CANCER 32 0.0035
607 LEUKOPENIA 173 0.0035
608 FEMUR FRACTURE 107 0.0035
609 HIP FRACTURE 111 0.0034
610 TOOTH FRACTURE 38 0.0034
611 NIGHT SWEATS 111 0.0034
612 NEPHROLITHIASIS 158 0.0034
613 BLOOD COUNT ABNORMAL 52 0.0034
614 EATING DISORDER 73 0.0034
615 SYNCOPE 343 0.0034
616 TACHYCARDIA 303 0.0034
617 HEART RATE IRREGULAR 77 0.0034
618 EPILEPSY 104 0.0034
619 INSURANCE ISSUE 52 0.0034
620 RESPIRATORY TRACT CONGESTION 54 0.0034
621 LYMPHADENOPATHY 120 0.0034
622 MUSCLE SPASMS 622 0.0034
623 GASTRIC HAEMORRHAGE 39 0.0034
624 SKIN DISORDER 113 0.0034
625 FATIGUE 2637 0.0034
626 ANGINA PECTORIS 97 0.0034
627 POST PROCEDURAL COMPLICATION 65 0.0034
628 ABSCESS 54 0.0034
629 METABOLIC ACIDOSIS 108 0.0034
630 FOOT FRACTURE 64 0.0034
631 CARDIAC ARREST 278 0.0034
632 GASTROINTESTINAL DISORDER 301 0.0034
633 MUSCULOSKELETAL CHEST PAIN 52 0.0034
634 TENDERNESS 35 0.0034
635 HALLUCINATION 253 0.0034
636 BODY TEMPERATURE DECREASED 33 0.0033
637 COUGH 940 0.0033
638 DYSKINESIA 136 0.0033
639 RESPIRATORY DISORDER 100 0.0033
640 URINARY INCONTINENCE 99 0.0033
641 SPINAL OPERATION 41 0.0033
642 GENERAL PHYSICAL HEALTH DETERIORATION 385 0.0033
643 DIALYSIS 47 0.0033
644 OSTEOPOROSIS 136 0.0033
645 THERAPEUTIC PRODUCT EFFECT DECREASED 148 0.0033
646 UNRESPONSIVE TO STIMULI 85 0.0033
647 NEUROLEPTIC MALIGNANT SYNDROME 39 0.0033
648 TOOTH DISORDER 73 0.0033
649 HAEMATOMA 85 0.0033
650 UPPER LIMB FRACTURE 65 0.0033
651 FACE OEDEMA 55 0.0033
652 PAIN IN EXTREMITY 956 0.0032
653 BACK PAIN 752 0.0032
654 BLOOD TRIGLYCERIDES INCREASED 57 0.0032
655 INABILITY TO AFFORD MEDICATION 32 0.0032
656 APHASIA 97 0.0032
657 HAEMORRHAGE INTRACRANIAL 48 0.0032
658 BACK DISORDER 52 0.0032
659 SEROTONIN SYNDROME 61 0.0032
660 PALPITATIONS 371 0.0032
661 ARRHYTHMIA 150 0.0032
662 COVID-19 554 0.0032
663 MUSCLE ATROPHY 40 0.0032
664 INTENTIONAL DOSE OMISSION 90 0.0032
665 SCAB 36 0.0032
666 RESPIRATORY DISTRESS 87 0.0031
667 DERMATITIS 66 0.0031
668 HALLUCINATION, AUDITORY 50 0.0031
669 MALAISE 1377 0.0031
670 TOOTH EXTRACTION 39 0.0031
671 HOSPITALISATION 481 0.0031
672 PANCREATITIS ACUTE 70 0.0031
673 CHEST PAIN 576 0.0031
674 RASH MACULO-PAPULAR 69 0.0031
675 STATUS EPILEPTICUS 35 0.0031
676 DRUG INTERACTION 491 0.0031
677 MUSCLE RIGIDITY 37 0.0031
678 TREATMENT NONCOMPLIANCE 169 0.0031
679 FLATULENCE 175 0.0031
680 IRRITABLE BOWEL SYNDROME 66 0.0031
681 BALANCE DISORDER 266 0.0031
682 ANXIETY 868 0.0030
683 THYROID DISORDER 47 0.0030
684 DYSSTASIA 89 0.0030
685 SPINAL FRACTURE 61 0.0030
686 SINUS CONGESTION 41 0.0030
687 ATAXIA 36 0.0030
688 TOXIC EPIDERMAL NECROLYSIS 46 0.0030
689 IMMUNODEFICIENCY 45 0.0030
690 BRAIN OEDEMA 38 0.0030
691 CHOLECYSTECTOMY 34 0.0030
692 RESPIRATORY ARREST 82 0.0030
693 TYPE 2 DIABETES MELLITUS 100 0.0030
694 TREMOR 493 0.0030
695 CONFUSIONAL STATE 480 0.0030
696 HEART RATE DECREASED 104 0.0030
697 CATARACT 176 0.0030
698 SECRETION DISCHARGE 37 0.0030
699 RESPIRATORY DEPRESSION 36 0.0029
700 INFECTION 425 0.0029
701 ERYTHEMA 603 0.0029
702 SINUSITIS 299 0.0029
703 LOWER RESPIRATORY TRACT INFECTION 132 0.0029
704 SURGERY 170 0.0029
705 PRESCRIBED OVERDOSE 56 0.0029
706 JOINT SWELLING 349 0.0029
707 INFLUENZA 322 0.0029
708 APATHY 42 0.0029
709 FIBROMYALGIA 70 0.0029
710 INTENTIONAL PRODUCT USE ISSUE 251 0.0029
711 GAIT DISTURBANCE 548 0.0029
712 NECK PAIN 160 0.0029
713 PRODUCT DOSE OMISSION IN ERROR 81 0.0029
714 LIVER FUNCTION TEST ABNORMAL 83 0.0029
715 CHILLS 334 0.0028
716 PERIPHERAL COLDNESS 39 0.0028
717 FEELING COLD 79 0.0028
718 WRIST FRACTURE 34 0.0028
719 JOINT RANGE OF MOTION DECREASED 38 0.0028
720 OROPHARYNGEAL PAIN 262 0.0028
721 HEADACHE 1772 0.0028
722 DIZZINESS 1408 0.0028
723 UNEVALUABLE EVENT 213 0.0028
724 CHEST DISCOMFORT 287 0.0028
725 FUNGAL INFECTION 93 0.0028
726 DYSARTHRIA 105 0.0028
727 MUSCULOSKELETAL PAIN 146 0.0028
728 THERAPEUTIC RESPONSE UNEXPECTED 125 0.0028
729 NASAL CONGESTION 163 0.0028
730 GLYCOSYLATED HAEMOGLOBIN INCREASED 70 0.0028
731 CORONARY ARTERY OCCLUSION 38 0.0028
732 HEART RATE INCREASED 272 0.0027
733 HERNIA 53 0.0027
734 POOR QUALITY SLEEP 59 0.0027
735 BEDRIDDEN 36 0.0027
736 TOOTH INFECTION 36 0.0027
737 COLD SWEAT 48 0.0027
738 BURSITIS 33 0.0027
739 HYPOAESTHESIA 407 0.0027
740 CHOKING 53 0.0027
741 SCHIZOPHRENIA 33 0.0027
742 LIMB DISCOMFORT 84 0.0027
743 HEAD DISCOMFORT 48 0.0027
744 DISORIENTATION 107 0.0027
745 ABDOMINAL DISCOMFORT 452 0.0027
746 GALLBLADDER DISORDER 48 0.0027
747 THERAPEUTIC RESPONSE DECREASED 163 0.0027
748 PANCREATITIS 142 0.0027
749 MUSCULOSKELETAL DISCOMFORT 46 0.0027
750 MIGRAINE 255 0.0027
751 BONE PAIN 156 0.0027
752 CHROMATURIA 60 0.0027
753 TOOTHACHE 48 0.0026
754 SARS-COV-2 TEST POSITIVE 35 0.0026
755 MASS 37 0.0026
756 MOVEMENT DISORDER 85 0.0026
757 SEIZURE 304 0.0026
758 ARTHRALGIA 1093 0.0026
759 SKIN LESION 72 0.0026
760 ABDOMINAL PAIN UPPER 536 0.0026
761 NASOPHARYNGITIS 477 0.0026
762 RASH 1128 0.0026
763 DIABETIC KETOACIDOSIS 62 0.0026
764 IMMUNE SYSTEM DISORDER 34 0.0026
765 MOBILITY DECREASED 185 0.0026
766 HAIR COLOUR CHANGES 32 0.0026
767 THROAT IRRITATION 115 0.0026
768 PAIN 1569 0.0026
769 RHINORRHOEA 165 0.0026
770 COGNITIVE DISORDER 118 0.0025
771 MYELOSUPPRESSION 91 0.0025
772 ANAPHYLACTIC SHOCK 65 0.0025
773 HYPOAESTHESIA ORAL 38 0.0025
774 LETHARGY 145 0.0025
775 BLOOD PRESSURE FLUCTUATION 60 0.0025
776 PHOTOPHOBIA 47 0.0025
777 DEPRESSION 568 0.0025
778 GAIT INABILITY 83 0.0025
779 WEIGHT INCREASED 556 0.0025
780 MUCOSAL INFLAMMATION 65 0.0025
781 CARDIOVASCULAR DISORDER 63 0.0025
782 CYANOSIS 39 0.0025
783 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 445 0.0025
784 PROSTATIC SPECIFIC ANTIGEN INCREASED 34 0.0025
785 OFF LABEL USE 2154 0.0025
786 GLOSSODYNIA 55 0.0025
787 LOWER LIMB FRACTURE 47 0.0024
788 CARDIAC DISORDER 227 0.0024
789 DRY EYE 121 0.0024
790 HYPOKINESIA 35 0.0024
791 LUNG NEOPLASM MALIGNANT 99 0.0024
792 ROAD TRAFFIC ACCIDENT 100 0.0024
793 PANCREATIC CARCINOMA 69 0.0024
794 PERICARDITIS 40 0.0024
795 THERAPY INTERRUPTED 170 0.0024
796 IMPAIRED HEALING 78 0.0024
797 EYE PAIN 134 0.0024
798 GASTRIC CANCER 60 0.0024
799 EAR PAIN 46 0.0024
800 ANHEDONIA 62 0.0024
801 BLISTER 132 0.0023
802 CIRCULATORY COLLAPSE 40 0.0023
803 PRODUCT USE COMPLAINT 37 0.0023
804 RETCHING 50 0.0023
805 ACUTE HEPATIC FAILURE 32 0.0023
806 GLAUCOMA 45 0.0023
807 LYMPHOPENIA 33 0.0023
808 INTENTIONAL PRODUCT MISUSE 204 0.0023
809 ERUCTATION 45 0.0023
810 MOUTH ULCERATION 49 0.0023
811 WOUND 65 0.0023
812 SKIN EXFOLIATION 196 0.0023
813 PRODUCT DOSE OMISSION ISSUE 682 0.0023
814 PALLOR 63 0.0023
815 VERTIGO 141 0.0023
816 MIDDLE INSOMNIA 43 0.0023
817 PHOTOSENSITIVITY REACTION 38 0.0023
818 ABDOMINAL PAIN LOWER 58 0.0023
819 ALOPECIA 449 0.0023
820 AGEUSIA 57 0.0023
821 SKIN DISCOLOURATION 105 0.0023
822 BLOOD GLUCOSE DECREASED 109 0.0023
823 BLOOD GLUCOSE INCREASED 427 0.0023
824 AMNESIA 147 0.0023
825 MEMORY IMPAIRMENT 309 0.0022
826 ILLNESS 231 0.0022
827 PRURITUS 859 0.0022
828 DYSGEUSIA 166 0.0022
829 KNEE ARTHROPLASTY 47 0.0022
830 PRODUCT ADMINISTRATION ERROR 45 0.0022
831 AGRANULOCYTOSIS 41 0.0022
832 FEELING ABNORMAL 528 0.0022
833 ORAL HERPES 43 0.0022
834 THERAPY NON-RESPONDER 99 0.0022
835 RHEUMATOID ARTHRITIS 247 0.0022
836 MYALGIA 369 0.0022
837 RASH ERYTHEMATOUS 103 0.0022
838 EAR INFECTION 57 0.0021
839 BONE DISORDER 39 0.0021
840 PRODUCT USE ISSUE 401 0.0021
841 TINNITUS 98 0.0021
842 HYPERSENSITIVITY 395 0.0021
843 DIPLOPIA 55 0.0021
844 EXPOSURE DURING PREGNANCY 131 0.0021
845 CONJUNCTIVITIS 39 0.0021
846 PRODUCT USE IN UNAPPROVED INDICATION 519 0.0021
847 HAEMORRHAGE 217 0.0021
848 PARAESTHESIA 324 0.0021
849 BLOOD GLUCOSE ABNORMAL 38 0.0021
850 ANAPHYLACTIC REACTION 112 0.0020
851 HIP ARTHROPLASTY 31 0.0020
852 NEUROTOXICITY 35 0.0020
853 GENERALISED TONIC-CLONIC SEIZURE 33 0.0020
854 DEATH 1707 0.0020
855 FEELING JITTERY 37 0.0019
856 HYPERHIDROSIS 250 0.0019
857 NERVOUSNESS 101 0.0019
858 SPEECH DISORDER 101 0.0019
859 ISCHAEMIC STROKE 34 0.0019
860 VISION BLURRED 261 0.0019
861 HEMIPARESIS 32 0.0019
862 LACRIMATION INCREASED 57 0.0019
863 TREATMENT FAILURE 155 0.0019
864 SKIN CANCER 40 0.0019
865 INJURY 130 0.0018
866 ABNORMAL BEHAVIOUR 73 0.0018
867 MUSCLE TWITCHING 42 0.0018
868 UNDERDOSE 133 0.0018
869 DISABILITY 36 0.0018
870 HYPOACUSIS 78 0.0018
871 NEOPLASM MALIGNANT 120 0.0018
872 SEDATION 47 0.0018
873 SWOLLEN TONGUE 56 0.0018
874 DRY SKIN 239 0.0018
875 ADVERSE EVENT 165 0.0018
876 INCREASED APPETITE 34 0.0018
877 RASH GENERALISED 46 0.0018
878 EOSINOPHILIA 31 0.0018
879 ACTIVITIES OF DAILY LIVING IMPAIRED 35 0.0018
880 CEREBROVASCULAR ACCIDENT 297 0.0018
881 SWELLING FACE 114 0.0017
882 SNEEZING 39 0.0017
883 FLUSHING 176 0.0017
884 CONVULSION 99 0.0017
885 ECZEMA 90 0.0017
886 THERAPY CESSATION 88 0.0017
887 DYSTONIA 33 0.0017
888 LACTIC ACIDOSIS 55 0.0017
889 MYOCARDIAL INFARCTION 295 0.0017
890 PRODUCT PHYSICAL ISSUE 34 0.0017
891 DEPRESSED MOOD 89 0.0017
892 FEELING HOT 103 0.0017
893 VISUAL IMPAIRMENT 208 0.0017
894 MULTIPLE SCLEROSIS 80 0.0017
895 DISCOMFORT 101 0.0017
896 RASH PAPULAR 37 0.0016
897 PANIC ATTACK 60 0.0016
898 JOINT STIFFNESS 43 0.0016
899 GASTRIC DISORDER 56 0.0016
900 THROAT TIGHTNESS 44 0.0016
901 OSTEONECROSIS 53 0.0016
902 PSORIATIC ARTHROPATHY 65 0.0016
903 URTICARIA 267 0.0016
904 TOOTH LOSS 33 0.0016
905 BURNING SENSATION 111 0.0016
906 EYE DISORDER 52 0.0016
907 MENTAL IMPAIRMENT 38 0.0016
908 AGITATION 115 0.0016
909 PRODUCT DOSE OMISSION 100 0.0015
910 ILL-DEFINED DISORDER 93 0.0015
911 FEAR 41 0.0015
912 PRODUCT PRESCRIBING ERROR 36 0.0015
913 NERVOUS SYSTEM DISORDER 47 0.0015
914 VISUAL ACUITY REDUCED 50 0.0015
915 MOOD ALTERED 41 0.0015
916 SYSTEMIC LUPUS ERYTHEMATOSUS 53 0.0015
917 MOOD SWINGS 47 0.0015
918 NIGHTMARE 51 0.0015
919 PRODUCT AVAILABILITY ISSUE 33 0.0014
920 ABNORMAL DREAMS 40 0.0014
921 ADVERSE DRUG REACTION 128 0.0014
922 DISEASE RECURRENCE 66 0.0014
923 TARDIVE DYSKINESIA 39 0.0014
924 ABASIA 34 0.0014
925 RASH MACULAR 48 0.0014
926 ERECTILE DYSFUNCTION 35 0.0014
927 MULTIPLE SCLEROSIS RELAPSE 93 0.0014
928 SUICIDAL IDEATION 124 0.0014
929 OCULAR HYPERAEMIA 64 0.0013
930 LIVER INJURY 33 0.0013
931 EYE SWELLING 50 0.0013
932 COMA 64 0.0013
933 INTENTIONAL OVERDOSE 86 0.0013
934 DEVICE DISLOCATION 58 0.0013
935 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 94 0.0013
936 DISTURBANCE IN ATTENTION 71 0.0013
937 MENTAL DISORDER 57 0.0013
938 EYE IRRITATION 75 0.0013
939 AGGRESSION 65 0.0013
940 VAGINAL HAEMORRHAGE 56 0.0013
941 SUICIDE ATTEMPT 78 0.0013
942 IRRITABILITY 75 0.0012
943 BONE DENSITY DECREASED 39 0.0012
944 TOXICITY TO VARIOUS AGENTS 205 0.0012
945 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31 0.0012
946 ACCIDENTAL OVERDOSE 44 0.0012
947 EYE PRURITUS 40 0.0012
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 239 0.0012
949 DRUG INEFFECTIVE 1554 0.0012
950 THERAPEUTIC RESPONSE SHORTENED 39 0.0012
951 LIP SWELLING 39 0.0012
952 NEEDLE ISSUE 34 0.0012
953 INCORRECT DOSE ADMINISTERED 265 0.0012
954 DEVICE ISSUE 102 0.0011
955 DEVICE LEAKAGE 49 0.0011
956 ANGER 38 0.0011
957 MEDICATION ERROR 62 0.0011
958 EMOTIONAL DISTRESS 134 0.0011
959 BLINDNESS 44 0.0011
960 INJECTION SITE REACTION 73 0.0011
961 DRUG EFFECT INCOMPLETE 38 0.0010
962 INFLUENZA LIKE ILLNESS 86 0.0010
963 DRUG DOSE OMISSION 169 0.0010
964 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 56 0.0010
965 INJECTION SITE PRURITUS 66 0.0010
966 PROSTATE CANCER 78 0.0010
967 MATERNAL EXPOSURE DURING PREGNANCY 86 0.0010
968 CRYING 35 0.0010
969 ANGIOEDEMA 40 0.0009
970 OVERDOSE 186 0.0009
971 INJECTION SITE BRUISING 67 0.0008
972 DEVICE BREAKAGE 34 0.0008
973 WITHDRAWAL SYNDROME 35 0.0008
974 COMPLETED SUICIDE 69 0.0008
975 PRODUCT SUBSTITUTION ISSUE 47 0.0008
976 INJECTION SITE ERYTHEMA 100 0.0008
977 INJECTION SITE SWELLING 61 0.0008
978 NO ADVERSE EVENT 139 0.0008
979 EXTRA DOSE ADMINISTERED 31 0.0008
980 ACNE 58 0.0008
981 DEVICE MALFUNCTION 52 0.0007
982 INJECTION SITE PAIN 224 0.0007
983 PRODUCT QUALITY ISSUE 97 0.0007
984 BREAST CANCER 64 0.0007
985 PSORIASIS 87 0.0007
986 DRUG EFFECT DECREASED 34 0.0006
987 INJECTION SITE HAEMORRHAGE 50 0.0006
988 BLADDER CANCER 35 0.0006
989 DEVICE DIFFICULT TO USE 33 0.0005
990 ACCIDENTAL EXPOSURE TO PRODUCT 49 0.0005
991 FOETAL EXPOSURE DURING PREGNANCY 38 0.0005
992 PRODUCT STORAGE ERROR 40 0.0005
993 DRUG WITHDRAWAL SYNDROME 33 0.0004
994 DRUG DEPENDENCE 36 0.0002